EnsoData Snags $20M to Improve Sleep Disorder Diagnostics
EnsoData raised $20 million in Series B funds for its AI-powered sleep diagnostics. The company’s technology aims to help clinicians diagnose sleep disorders faster and more consistently.
Wisp Unveils Diagnostics Arm
Wisp is now offering at-home testing for Chlamydia, Gonorrhea, Trichomaniasis and Mycoplasma Genitalium.
What Are Healthcare Organizations Getting Wrong about Email Security?
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.
Transforming Allergy Care: The Power of Advanced Diagnostics in Improving Patient Outcomes
Getting the correct food allergy diagnosis leads to increased diet diversity and potentially improved nutrition when suspected allergies are ruled out, making it critical to take the right diagnostic approach from the beginning.
Harnessing Innovative Transplant Diagnostics to Improve Patient Outcomes
Innovative transplant diagnostics and novel paradigms that give a clearer picture of a recipient’s immune system at various phases of the transplant journey can enable transplant teams to mitigate some of these challenges and make more accurate and faster donor assessments, as well as more informed and patient-centric decisions post-transplant.
Signify Health Unveils Chronic Kidney Disease Evaluation
Home care company Signify Health announced Tuesday that it added an in-home kidney health evaluation to its platform. Based on the results of the evaluation, the company can refer patients to their primary care physician or a specialist if they’re in need of further treatment.
Human Longevity strikes a SPAC deal to go public and fuel U.S., global expansion
Human Longevity, Inc., a startup founded by genomics pioneer J. Craig Venter, plans to join the public markets via a SPAC merger. If the business combination closes, HLI would receive about $345 million for continued commercialization of its platform that uses genomics, AI, and other technologies for early disease detection and other strategies intended to help people live longer.
presented by
A Path to Healing: Discovering Arizona’s PTSD Treatment Centers
Explore top PTSD treatment centers in Arizona, offering personalized care, holistic therapies and expert support to help individuals heal and reclaim their lives.
Freenome nabs $160M to advance blood-based colorectal cancer test
The South San Francisco company intends to use the funding to launch its pivotal trial for its blood-based colorectal cancer screening and submit its test for parallel review for CMS coverage.
Report: Diagnosis-related failures are the top cause of medical professional liability claims
The report from Coverys analyzed 10,618 closed medical professional liability claims from 2013 to 2017. Diagnosis-related errors and failures make up 33 percent of all claims and 47 percent of indemnity payments.
This diagnostic device uses temperature to aid melanoma detection
Four recent engineering graduates from McMaster University, near Toronto, built a device to detect melanoma that measures the temperature differences between melanoma and normal tissue.
CareFirst BCBS, ExoDx band together on studies for diagnostic tests
Through CareFirst's new HealthWorx program, the organizations are working together on evidence development studies for ExoDx diagnostic tests.
presented by
The Top 5 Home Care Franchise Opportunities in the U.S.
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.
Philly team that won Qualcomm Tricorder contest focused on human interaction first, diagnostics second
Some of the members of Basil Leaf Technologies, also known as team Final Frontier, gathered in Philadelphia to share their insights on the Qualcomm Tricorder Prize experience and what comes next.
Theranos saga teaches these lessons for startups
The dramatic downfall of Theranos holds key lessons for startup entrepreneurs who want to avoid CEO Holmes's fate.
Can a smartphone-enabled testing platform make DIY urine tests more accurate?
The researchers’ next goal is to make a more integrated system so that the processing is done on the phone so the user can see the results as soon as testing is done.
FDA gives greenlight to Roche C.difficile test (Morning Read)
FDA gave Roche the greenlight for a C.difficile test.
How could mobile health tools ease the Ebola crisis?
As public health officials grapple with the enormous health crisis of the Ebola outbreak in Liberia, Sierra Leone, Guinea and most recently Congo, it raises the question of whether mobile health could make a difference. An Information Week article drew attention to some examples where mobile health tools could offer a way to trace the […]